Meningococcal surface fibril (Msf) binds to activated vitronectin and inhibits the terminal complement pathway to

Natalie J Griffiths1, Darryl J Hill, Elena Borodina

  • 1Schools of Cellular & Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.

Molecular Microbiology
|November 5, 2011
PubMed

Insights

Neisseria meningitidis uses a novel protein, Msf, to bind activated vitronectin, enhancing its survival against the human complement system. This binding mechanism provides serum resistance, crucial for meningococcal pathogenesis.

Area of Science:

  • Microbiology
  • Immunology
  • Bacterial Pathogenesis

Background:

  • Neisseria meningitidis (Nm) employs complement evasion for survival during infection.
  • The Nm adhesin Opc binds serum vitronectin to inhibit complement-mediated killing.
  • Vitronectin is a key serum protein involved in immune responses and coagulation.

Purpose of the Study:

  • To identify and characterize novel meningococcal adhesins involved in vitronectin binding.
  • To elucidate the mechanism by which meningococcal adhesins mediate complement resistance.
  • To assess the role of vitronectin binding in meningococcal pathogenesis and survival.

Main Methods:

  • Bacterial surface protein characterization and binding assays.
  • Analysis of complement-mediated killing and serum resistance.
  • In vitro and in vivo competition assays using bacterial mutants.
  • Peptide-based inhibition of protein-vitronectin interactions.

Main Results:

  • A novel adhesin, meningococcal surface fibril (Msf), mediates binding to activated vitronectin (aVn).
  • Both Msf and Opc bind aVn, conferring serum resistance, with enhanced resistance in co-expressing strains.
  • Blocking Msf-aVn interactions reversed aVn-mediated inhibition of complement component C5b-9 formation and serum killing.
  • Mutants lacking Msf or Opc were depleted in mixed population survival studies, indicating their importance for fitness.

Conclusions:

  • Meningococcal surface fibril (Msf) is a novel adhesin that binds activated vitronectin, contributing to serum resistance.
  • Vitronectin binding represents a significant survival strategy for Neisseria meningitidis, with redundant mechanisms (Opc and Msf) evolved for pathogenesis.
  • Targeting Msf-vitronectin interactions could be a potential therapeutic strategy against meningococcal infections.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...